FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula: , wherein R1 represents C1-4 alkyl; R2 can be specified in C1-4-alkyl, 6-merous aryl, heteroaryl, partially or completely saturated 6-merous heterocyclyl containing 1 heteroatom N or O, C3-10-cycloalkyl, 6-merous aryl-C1-6-alkyl, heteroaryl-C1-6-alkyl or R1 and R2 together with N to which they are attached, can form a 10-merous heteroaryl or a 5-10-merous heterocyclyl group optionally containing 1 additional heteroatom specified in O, N and S, each of which can be optionally substituted, R5 is specified in H, C1-2-alkyl, halogen; R6 is specified in a 6-10-merous aryl, 6-9-merous heteroaryl containing 1-2 heteroatoms specified in O and N; R8 represents H; and to compositions for inhibiting a fatty acid amide hydrolase (FAAH) enzyme.
EFFECT: preparing new pharmaceutical compounds.
20 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | 2015 |
|
RU2760719C2 |
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
8-AZABICYCLO[3,2,1]OCTAN-8-CARBOXAMIDE DERIVATIVE | 2010 |
|
RU2574597C2 |
DERIVATIVES OF SUBSTITUTED TRIAZOLDIAMINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2274639C2 |
BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS | 2013 |
|
RU2667909C2 |
METHOD OF PRODUCING Α-DIAZOCARBONYL COMPOUNDS IN AQUEOUS MEDIUM | 2018 |
|
RU2686489C1 |
PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION | 2014 |
|
RU2665709C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
Authors
Dates
2015-06-20—Published
2009-12-23—Filed